SymBioVault presents at CV Summit 2026 in Zurich
SymBioVault and CoreLedger presented a joint concept at CV Summit 2026, exploring the potential use of blockchain technology in personalized microbiome biobanking.
Events
Back to News
Company News
SymBioVault launches a joint research project with ZHAW
SymBioVault has launched a joint research project with the ZHAW Zurich University of Applied Sciences to advance the scientific and technical foundations of personalized microbiome biobanking.
The Proof-of-Concept study focuses on the collection, safety testing, multi-omics analysis and long-term cryopreservation of autologous human microbiome samples. Its aim is to validate technical feasibility and sample viability for future microbiome biobanking applications in personalized medicine and research.
The project, launched in July 2026, brings together SymBioVault and researchers from ZHAW’s Institute of Chemistry and Biotechnology (ICBT), combining applied scientific expertise with SymBioVault’s focus on developing solutions for the preservation and future use of the personal microbiome.
For SymBioVault, this collaboration represents an important step in building the scientific foundation behind our approach. By working with an established Swiss research institution, we aim to generate practical evidence around the methods required to collect, characterize and preserve personal microbiome samples over the long term.
The project also strengthens SymBioVault’s connections within the Swiss research and innovation ecosystem and supports our broader goal of making the personal microbiome a resource that can be preserved today for potential future applications in medicine and research.
External link: Read the official ZHAW project description.
Keep reading
